Epstein Secrets

with a notably international outlook, is president emeritus of the Missouri Botanical Garden and George Engelmann Professor of Botany Emeritus at Washington University in St. Louis. In addition, Dr. Raven is a Trustee of the National Geographic Society and Chairman of the Society's Committee for Research and Expl

ears at the National Institutes of Health as a Howard Hughes Medical Institute-NIH Research Scholar. Agus has had a long and varied career. At the Memorial Sloan-Kettering Cancer Center in New York, he was an attending physician in the Department of Medical Oncology and head of the Laboratory of Tumor Biology. He was also Assistan

xome sequencing, and RNA expression analysis—what Washington University pro- fessor of genetics and Genome Institute co-d

ancer How “exceptionalresponders’ ‘arerevolutionizing treatment for the deadly desease BY KAT MCGOWAN UST LIKE EVERY NEW drug the oncologists at Memorial Sloan-Kettering Cancer Center test- ed against bladder cancer in the last 20 years, this one didn’t seem to be doing any good. For- ty-four people in the study were given everolim

ylvania School of Medicine in 1991. Agus completed his residency training at Johns Hopkins Hospital and completed his oncology fellowship training at the Memorial Sloan-Kettering Cancer Center in New York. He spent two years at the National Institutes of Health as a Howard Hughes Medical Institute-NIH Research Scholar. Agus has had a long

ity with a notably international outlook, is president emeritus of the Missouri Botanical Garden and George Engelmann Professor of Botany Emeritus at Washington University in St. Louis. In addition, Dr. Raven is a Trustee of the National Geographic Society and Chairman of the Society’s Committee for Research and Explora